Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WHR stock price vs SUPN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUPN's multiple
Needs SUPN P/E.
Implied fair value · at WHR's multiple
Needs Annual EPS is negative, WHR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WHIRLPOOL CORP /DE/ · implied price per share
Bear
-$46.25
Base
-$39.05
Bull
-$26.28
SUPERNUS PHARMACEUTICALS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BEST BUY CO INC
WHR vs BBY
HOME DEPOT, INC.
WHR vs HD
GENERAL ELECTRIC CO
WHR vs GE
HELEN OF TROY LTD
WHR vs HELE
NEWELL BRANDS INC.
WHR vs NWL
Spectrum Brands Holdings, Inc.
WHR vs SPB
Jazz Pharmaceuticals plc
WHR vs JAZZ
INCYTE CORP
WHR vs INCY
ANI PHARMACEUTICALS INC
WHR vs ANIP
Vanda Pharmaceuticals Inc.
WHR vs VNDA
Harmony Biosciences Holdings, Inc.
WHR vs HRMY
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WHR deserves a higher multiple because its positive earnings and ROIC are more representative than SUPN's loss-making profile, then favor WHR on a fundamental valuation basis; however, do not rely on SUPN-implied $1065.44 price because the SUPN comp is not economically comparable.
WHR trades at 0.2x P/S versus SUPN at 3.9x, which mechanically creates the huge implied upside in the model. However, the gap is driven by very different business profiles: WHR is a mature, low-growth appliance manufacturer, while SUPN is a smaller, higher-multiple biotech/pharma name with negative earnings and higher top-line growth.
Supporting Metrics
